Fig. 6
From: Calibrated automated thrombogram II: removing barriers for thrombin generation measurements
Dose-dependent effect of DOACs on thrombin generation measured by ST®-Genesia and CAT-II. Plasma samples were spiked with dabigatran, apixaban or rivaroxaban (0–250 ng/ml) and thrombin generation was measured with ST®-Genesia and CAT-II. Lag time (A,D), peak height (B,E) and ETP (C,F) were determined in thrombin generation curves obtained with ST®-Genesia and CAT-II methods